0.5787

0.24% -0.0014

After Hours: .58 0.0013 +0.22%

Outset Medical Inc (OM)

Overview News Price History Option Chain Financials Why OM Down? Discussions Forecast

Outset Medical Inc stock is traded at $0.5787, with a volume of 647.80K. It is down -0.24% in the last 24 hours and down -25.81% over the past month. Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Previous Close:

$0.5801

Open:

$0.5916

24h Volume:

647.80K

Relative Volume:

0.61

Market Cap:

$31.19M

Revenue:

$114.73M

Net Income/Loss:

$-140.94M

P/E Ratio:

-0.2097

EPS:

-2.76

Net Cash Flow:

$-126.18M

1W Performance:

-20.07%

1M Performance:

-25.81%

6M Performance:

+28.49%

1Y Performance:

-76.19%

1-Day Range:

$0.56

$0.6087

1-Week Range:

$0.5349

$0.7199

52-Week Range:

$0.435

$5.22

Outset Medical Inc Stock (OM) Company Profile

Name

Outset Medical Inc

Sector

Healthcare (1172)

Industry

Medical Devices (161)

Phone

669-231-8200

Address

3052 ORCHARD DRIVE, SAN JOSE

Employee

354

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

OM's Discussions on Twitter

Compare OM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OM Outset Medical Inc	0.5787	31.19M	114.73M	-140.94M	-126.18M	-2.76
ABT Abbott Laboratories	130.28	225.95B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	96.42	142.29B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	363.84	138.83B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	91.51	117.34B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	68.51	40.28B	5.72B	4.17B	259.90M	6.97

Outset Medical Inc Stock (OM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Apr-08-24	Initiated	BTIG Research	Buy
Apr-05-24	Upgrade	CL King	Neutral → Buy
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-02-22	Resumed	BofA Securities	Buy
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-18-21	Initiated	Cowen	Outperform
Apr-19-21	Initiated	Wells Fargo	Overweight
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	Barclays	Overweight
Oct-12-20	Initiated	BofA Securities	Buy
Oct-12-20	Initiated	Goldman	Buy
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight
Oct-12-20	Initiated	SVB Leerink	Mkt Perform
Oct-12-20	Initiated	Stifel	Buy

View All

Outset Medical Inc Stock (OM) Latest News

Mar 12, 2025

Investigation announced for Long-Term Investors in shares of Outset Medical, Inc. (NASDAQ: OM) - openPR

Mar 12, 2025

Mar 11, 2025

Outset Medical corrects preferred stock error By Investing.com - Investing.com South Africa

Mar 11, 2025

Outset Medical corrects preferred stock error - Investing.com

Mar 11, 2025

Mar 10, 2025

Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineOM - accessnewswire.com

Mar 10, 2025

Mar 05, 2025

Outset Medical Shines Amid Revenue Growth and Operational Gains - TipRanks

Mar 05, 2025

Mar 04, 2025

Levi & Korsinsky Reminds Outset Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM - accessnewswire.com

Mar 04, 2025

Mar 03, 2025

OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com

Mar 03, 2025

Outset Medical, Inc. Class Action: Levi & Korsinsky Reminds Outset Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024OM - ACCESS Newswire

Mar 03, 2025

Mar 02, 2025

Outset Medical, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your RightsOM - ACCESS Newswire

Mar 02, 2025

Mar 01, 2025

Outset Medical Stock Faces Major Challenges Amid Market Decline - Evrim Ağacı

Mar 01, 2025

Feb 28, 2025

Outset Medical, Inc. SEC 10-K Report - TradingView

Feb 28, 2025

Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now - MSN

Feb 28, 2025

OM LAWSUIT ALERT: Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 28, 2025

Shareholders that lost money on Outset Medical, Inc.(OM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 28, 2025

Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM SharesHagens Berman - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical, Inc. LawsuitOM - ACCESS Newswire

Feb 27, 2025

OM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 27, 2025

Shareholders that Lost Money on Outset Medical, Inc. (OM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 27, 2025

Feb 24, 2025

Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference -February 24, 2025 at 04:03 pm EST - Marketscreener.com

Feb 24, 2025

Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference - GlobeNewswire

Feb 24, 2025

Can Outset Medical's New Dialysis Tech Disrupt a $100B Industry? Key Conference Insights Coming - StockTitan

Feb 24, 2025

Feb 23, 2025

Outset Medical (NASDAQ:OM) Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat

Feb 23, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc.(OM) Shareholders - ACCESS Newswire

Feb 23, 2025

Outset Medical (NASDAQ:OM) Announces Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat

Feb 23, 2025